| Sitagliptin | IC50 | 100000.0 [1] |
| Vildagliptin | IC50 | 230.0 [1] |
| Vildagliptin | Ki | 68.0 [1], 95.0 [2] |
| Alogliptin | IC50 | 100000.0 [1] |
| Linagliptin | IC50 | 10000.0 [1], 100000.0 [2] |
| Saxagliptin | IC50 | 100.0 [1], 104.0 [2] |
| Saxagliptin | Ki | 71.0 [1] |
| Talabostat | IC50 | 2.0 [1], 2.2 [2] |
| Talabostat | Ki | 0.76 [1] |
| Ala-boroPro | IC50 | 2.8 [1], 360000.0 [2] |
| Ala-boroPro | Ki | 0.53 [1] |
| Allo-Ile-Isoindoline | IC50 | 240.0 [1], 290.0 [2] |
| (2S,3S)-2-Amino-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one;2,2,2-trifluoroacetic acid | IC50 | 86000.0 [1] |
| (2S)-1-[2-[[(3Ar,6aS)-5-methoxy-1,2,3,3a,4,5,6,6a-octahydropentalen-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile | IC50 | 37.0 [1], 430.0 [2] |
| N4-(4-Chlorobenzyl)-2,4-diaminobutanoylpiperidine | IC50 | 76600.0 [1], 78600.0 [2] |
| 1-Pentanone, 2-amino-3-methyl-1-(3-thiazolidinyl)-, (2S,3S)- | IC50 | 1600.0 [1], 6600.0 [2] |
| (R)-1-(2-Aminoacetyl)pyrrolidin-2-ylboronic acid | IC50 | 98.0 [1] |
| (R)-1-(2-Aminoacetyl)pyrrolidin-2-ylboronic acid | Ki | 0.41 [1] |
| N-(1-Napthalenecarbonyl)-Gly-boroPro | IC50 | 420.0 [1], 2700.0 [2] |
| N-[4-[(1S)-1-Amino-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl]cyclohexyl]-2,4-difluorobenzenesulfonamide | IC50 | 2720.0 [1] |
| Val-boroAla | IC50 | 3200.0 [1] |
| Val-boroAla | Ki | 50.0 [1] |
| ((2S,4S)-4-(4-(4-Nitrophenyl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone | IC50 | 30.0 [1], 30.2 [2] |
| Ile-Isoindoline | IC50 | 4300.0 [1] |
| (2S,3S)-3-Amino-2-[4-(4-fluorophenyl)phenyl]-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxobutanamide | IC50 | 69.0 [1], 69000.0 [2] |
| Sitagliptin Hydrochloride | IC50 | 100000.0 [1] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide;2,2,2-trifluoroacetic acid | IC50 | 100000.0 [1] |
| (5-(2,4-Dichlorophenyl)-2-(2-methoxyphenyl)-7-methylimidazo[1,2-a]pyrimidin-6-yl)methanamine | Ki | 10000.0 [1] |
| Glu-boroAla | IC50 | 7000000.0 [1] |
| Glu-boroAla | Ki | 2100.0 [1] |
| (S)-2,6-Diamino-1-(isoindolin-2-yl)hexan-1-one | IC50 | 500.0 [1] |
| (2S,3S)-3-Amino-2-[4-(4-fluorophenyl)phenyl]-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxobutanamide;2,2,2-trifluoroacetic acid | IC50 | 69000.0 [1] |
| (S)-N-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide | IC50 | 12500.0 [1] |
| (2S,3S)-2-Amino-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one | IC50 | 86.0 [1], 86000.0 [2] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-5-yl)cyclohexyl]butanamide | IC50 | 3700.0 [1], 28000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-5-yl)cyclohexyl]butanamide | IC50 | 2600.0 [1], 25000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)cyclohexyl]butanamide | IC50 | 38000.0 [1] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-2-[4-(4-fluorophenyl)cyclohexyl]-N,N-dimethyl-4-oxobutanamide | IC50 | 15000.0 [1], 21000.0 [2] |
| (2r)-4-(2-Benzoyl-1,2-Diazepan-1-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)butan-2-Amine | IC50 | 48660.0 [1], 48977.88 [2] |
| (3Ar,6aS)-5-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N,N,5-trimethyl-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrole-2-carboxamide | IC50 | 2430.0 [1], 16900.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-2-[4-(2,6-dimethoxypyrimidin-4-yl)cyclohexyl]-N,N-dimethyl-4-oxobutanamide | IC50 | 40000.0 [1], 100000.0 [2] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)cyclohexyl]butanamide | IC50 | 50000.0 [1], 100000.0 [2] |
| N-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]-N-methylacetamide | IC50 | 12000.0 [1], 63000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]cyclohexyl]ethanamine | IC50 | 14000.0 [1], 93000.0 [2] |
| 1-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]piperidine-3-carboxamide | IC50 | 16000.0 [1], 32000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-(3,3-difluoropyrrolidin-1-yl)cyclohexyl]ethanamine | IC50 | 8100.0 [1], 100000.0 [2] |
| cis-(R)-2-(2,5-Difluorophenyl)-1-(4-(piperidin-1-yl)cyclohexyl)ethanamine | IC50 | 12000.0 [1], 28000.0 [2] |
| (R)-3-Amino-1-(2-benzoylpiperazin-1-yl)-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride | IC50 | 100000.0 [1] |
| Sitagliptin phosphate | IC50 | 20000.0 [1] |
| Teneligliptin | IC50 | 540.0 [1] |
| 2-Amino-3-methyl-1-pyrrolidin-1-YL-butan-1-one | IC50 | 11300.0 [1] |
| Omarigliptin | IC50 | 67000.0 [1] |
| (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide;hydrochloride | IC50 | 100000.0 [1] |
| Dutogliptin | IC50 | 663.0 [1] |
| Gosogliptin | IC50 | 5980.0 [1] |
| Grassystatin A | IC50 | 10000.0 [1] |
| Py(D)AlaboroPro | IC50 | 3400.0 [1] |
| Abt-279 | Ki | 30000.0 [1] |
| Imigliptin | IC50 | 100000.0 [1] |
| 1-Pentanone, 2-amino-3-methyl-1-(1-pyrrolidinyl)-, (2S,3S)- | IC50 | 13700.0 [1] |
| N-[4-((S)-1-Amino-2-oxo-2-thiazolidin-3-yl-ethyl)-cyclohexyl]-4-trifluoromethoxy-benzenesulfonamide | IC50 | 1400.0 [1] |
| Lys-Pro-CN | IC50 | 118.0 [1] |
| Dbpr-108 | IC50 | 50000.0 [1] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide | IC50 | 100000.0 [1] |
| 2-[3-[2-[2-Cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,3-dihydroisoindole | IC50 | 100000.0 [1] |
| (S)-2,6-Diamino-1-(piperidin-1-yl)hexan-1-one | IC50 | 28000.0 [1] |
| 2-Oxo-2-pyrrolidin-1-ylethanamine | IC50 | 1000000.0 [1] |
| 6-((3S,5S)-5-(Thiazolidine-3-carbonyl)pyrrolidin-3-ylamino)nicotinonitrile | IC50 | 3735.0 [1] |
| Phe-Pro-CN | IC50 | 330.0 [1] |
| (2S)-1-[(2S)-2-Amino-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-4-oxobutanoyl]pyrrolidine-2-carbonitrile | IC50 | 53.0 [1] |
| (2R)-2-[4-[[[(2S)-3-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,3-thiazolidine-2-carbonyl]amino]methyl]anilino]-3-methylbutanoic acid | IC50 | 13000.0 [1] |
| (R)-1-(2-(1-Oxoisoindolin-2-yl)acetyl)pyrrolidin-2-ylboronic acid | IC50 | 6500.0 [1] |
| CID 56658139 | IC50 | 53.0 [1] |
| Sitagliptin Analog 13 | IC50 | 100000.0 [1] |
| (3R)-3-Amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one | IC50 | 100000.0 [1] |
| (2S,3S)-2-Amino-1-(3-fluoropyrrolidin-1-yl)-3-methylpentan-1-one | IC50 | 11200.0 [1] |
| (2S)-1-[2-(Tert-butylamino)acetyl]pyrrolidine-2-carbonitrile | Ki | 3300.0 [1] |
| (2S)-1-[2-(Cyclopentylamino)acetyl]pyrrolidine-2-carbonitrile | Ki | 293.0 [1] |
| (2S)-2-Amino-4-[(2-chlorophenyl)methylamino]-1-piperidin-1-ylbutan-1-one | IC50 | 100000.0 [1] |
| DPPI 1c hydrochloride | IC50 | 30000.0 [1] |
| (2S,3S,5S)-5-((S)-2-Cyanopyrrolidine-1-carbonyl)-N,N,2-trimethylpyrrolidine-3-carboxamide | IC50 | 2500.0 [1] |
| 3-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N-(3,4-dimethoxyphenyl)-3-methylbutanamide | IC50 | 20000.0 [1] |
| Glu-boroPro | Ki | 2.6 [1] |
| (5-(2,4-Dichlorophenyl)-7-methyl-2-phenylimidazo[1,2-a]pyrimidin-6-yl)methanamine | Ki | 30000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]naphthalene-1-carboxamide | IC50 | 100000.0 [1] |
| (2S)-2-Cyano-1-(4-phenyl-L-phenylalanyl)pyrrolidine | IC50 | 9420.0 [1] |
| (2S,3S)-2-Amino-1-pyrrolidin-1-yl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]butan-1-one | IC50 | 100000.0 [1] |
| (3R)-3-Amino-4-(5-chloro-2-fluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one | IC50 | 98000.0 [1] |
| Gln-boroAla | Ki | 260.0 [1] |
| (R)-1-((S)-2-Acetamido-3-methylbutanoyl)pyrrolidin-2-ylboronic acid | Ki | 4300.0 [1] |
| 2-[[6-[(3R)-3-Amino-3-methylpiperidin-1-yl]-1,3-dimethyl-2,4-dioxopyrrolo[3,2-d]pyrimidin-5-yl]methyl]-4-fluorobenzonitrile | IC50 | 50000.0 [1] |
| N-[[(2S)-1-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]pyrrolidin-2-yl]methyl]cyclopropanecarboxamide | IC50 | 2900.0 [1] |
| N-[4-[(1S)-1-Amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | IC50 | 570.0 [1] |
| (S)-Pyrrolidin-2-yl(thiazolidin-3-yl)methanone | IC50 | 6129.0 [1] |
| (3R)-3-Amino-4-(2-fluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one | IC50 | 100000.0 [1] |
| (3R)-3-Amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,3,5-trifluorophenyl)butan-1-one | IC50 | 100000.0 [1] |
| (3R)-3-Amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,3,6-trifluorophenyl)butan-1-one | IC50 | 100000.0 [1] |
| (3R)-3-Amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,6-trifluorophenyl)butan-1-one | IC50 | 100000.0 [1] |
| (3R)-3-Amino-1-(3-ethyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | IC50 | 100000.0 [1] |
| 6-(4-((3S,5S)-5-(Thiazolidine-3-carbonyl)pyrrolidin-3-yl)piperazin-1-yl)nicotinonitrile | IC50 | 110.0 [1] |